Theme
Biotech '25: Neurology, CNS & Rare Disorders☆

ACOG+22.31%14.3%

MREO-82.46%14.3%

MTSR0.00%14.3%

RZLT-56.37%14.3%

SUPN-11.63%14.3%

VERA+6.92%14.3%

VYGR-44.39%14.3%
As of Oct 2, 2026, 9:55 PM ET
Biotech '25: Neurology, CNS & Rare Disorders Constituents
Alpha Cognition IncACOG | 14.3% | 4.60% | 1.68% | -2.31% | 4.60% | 40.00% | 51.67% | 79.13% | 22.31% | 8.33% | 8.33% | $141.3M |
Mereo BioPharma Group plcMREO | 14.3% | 3.52% | 13.78% | 34.66% | -2.00% | -13.71% | -2.98% | -84.83% | -82.46% | -91.36% | -85.33% | $60.7M |
Metsera, Inc.MTSR | 14.3% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 47.04% | 0.00% | 85.11% | 85.11% | $3.51B |
Rezolute, Inc.RZLT | 14.3% | -1.47% | -0.74% | -12.06% | -1.47% | 69.92% | 24.92% | 32.78% | -56.37% | -18.16% | -47.24% | $386.1M |
Supernus Pharmaceuticals, Inc.SUPN | 14.3% | 0.47% | -3.13% | -3.75% | 0.47% | -14.73% | -22.57% | 29.13% | -11.63% | 32.02% | 55.69% | $2.46B |
Vera Therapeutics, Inc.VERA | 14.3% | -1.84% | -13.93% | -12.48% | 0.71% | -38.37% | -23.49% | 32.30% | 6.92% | -24.87% | 67.33% | $2.18B |
Voyager Therapeutics, Inc.VYGR | 14.3% | -8.41% | -16.40% | -25.85% | -1.87% | -33.21% | -35.98% | -23.02% | -44.39% | -59.10% | -6.13% | $148.0M |
| Theme return | — | -0.45% | -2.68% | -3.87% | 0.06% | 6.07% | 1.76% | 90.58% | 18.17% | 46.96% | 253.28% | — |
| Average | 14.3% | -0.45% | -2.68% | -3.11% | 0.06% | 1.41% | -1.20% | 16.08% | -23.66% | -9.72% | 11.11% | $1.27B |
| Median | 14.3% | 0.00% | -0.74% | -3.75% | 0.00% | -13.71% | -2.98% | 32.30% | -11.63% | -18.16% | 8.33% | $386.1M |
| Std Dev | 0.0% | 3.94% | 9.38% | 17.41% | 2.12% | 36.75% | 28.40% | 49.80% | 35.27% | 54.07% | 58.11% | $1.31B |
| Min | 14.3% | -8.41% | -16.40% | -25.85% | -2.00% | -38.37% | -35.98% | -84.83% | -82.46% | -91.36% | -85.33% | $60.7M |
| Max | 14.3% | 4.60% | 13.78% | 34.66% | 4.60% | 69.92% | 51.67% | 79.13% | 22.31% | 85.11% | 85.11% | $3.51B |
| % Positive Tickers | 42.86% | 28.57% | 14.29% | 42.86% | 28.57% | 28.57% | 71.43% | 28.57% | 42.86% | 57.14% |